Home DailyMed 47ea6086-905b-4eee-9d72-db6d98996db8 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 01:39:22 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021567-001 REYATAZ ATAZANAVIR SULFATE EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 N021567-002 REYATAZ ATAZANAVIR SULFATE EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 N021567-003 REYATAZ ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 N021567-004 REYATAZ ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 172 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021567-001 REYATAZ EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021567-002 REYATAZ EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE / ORAL RLD 2003-06-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021567-003 REYATAZ EQ 200MG BASE CAPSULE / ORAL AB RLD 2003-06-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021567-004 REYATAZ EQ 300MG BASE CAPSULE / ORAL AB RLD, RS 2006-10-16 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 98 observed states.
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021567-001 6087383*PED 2019-06-21 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021567-002 6087383*PED 2019-06-21 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021567-003 6087383*PED 2019-06-21 Pediatric extension 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021567-004 6087383*PED 2019-06-21 Pediatric extension 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 N021567-001 6087383*PED 2019-06-21 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021567-002 6087383*PED 2019-06-21 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021567-003 6087383*PED 2019-06-21 Pediatric extension 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N021567-004 6087383*PED 2019-06-21 Pediatric extension 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021567-001 6087383*PED 2019-06-21 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021567-002 6087383*PED 2019-06-21 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021567-003 6087383*PED 2019-06-21 Pediatric extension b00525d2431f…2019-09-15 20:21 UTC 2019-09 N021567-004 6087383*PED 2019-06-21 Pediatric extension b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021567-001 6087383*PED 2019-06-21 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021567-002 6087383*PED 2019-06-21 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021567-003 6087383*PED 2019-06-21 Pediatric extension ea99ee380514…2019-07-19 19:46 UTC 2019-07 N021567-004 6087383*PED 2019-06-21 Pediatric extension ea99ee380514…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.